Pharming Group N.V.
PHGUF
$1.20
$0.021.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 38.46% | -30.81% |
| Total Depreciation and Amortization | -- | -- | -- | -4.26% | -50.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -3.62% | -3.62% |
| Total Other Non-Cash Items | -- | -- | -- | 122.99% | 10,198.99% |
| Change in Net Operating Assets | -- | -- | -- | 101.78% | -31.10% |
| Cash from Operations | -- | -- | -- | 638.65% | 381.15% |
| Capital Expenditure | -- | -- | -- | -21.61% | 23.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 427.09% | 177.91% |
| Cash from Investing | -- | -- | -- | 184.56% | 131.63% |
| Total Debt Issued | -- | -- | -- | -100.25% | -- |
| Total Debt Repaid | -- | -- | -- | 96.89% | -3,863.41% |
| Issuance of Common Stock | -- | -- | -- | -72.24% | -49.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -90.85% | -53.84% |
| Cash from Financing | -- | -- | -- | 50.62% | -4,293.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 1,290.16% | 109.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 177.65% | 106.17% |